Medscape7 天
U. S. Food and Drug Administration's Decision Regarding Bioequivalence of Levothyroxine Sodium
On June 24, The U.S. Food and Drug Administration(FDA) rejected a citizen petition filed in August 2003 regarding bioequivalence of levothyroxine sodium products and approved first-time generic ...
Medscape23 年
Unapproved Levothyroxine Products Hit in FDA Action
FDA is penalizing companies that filed late for approval of levothyroxine sodium products by forcing reductions in distribution over the next 2 years. The agency, in a guidance issued in mid-July ...